Skip to content
2000
Volume 13, Issue 13
  • ISSN: 1389-4501
  • E-ISSN: 1873-5592

Abstract

Epithelial ovarian cancer (EOC) is the most lethal gynecologic malignancy. Discovery of novel therapeutic opportunities for EOC is important for the improvement of clinical outcome of the patients. Emerging evidence is suggesting that epithelial-mesenchymal transition (EMT) plays a crucial role in the aggressiveness in EOC including increasing migration and invasion ability, contributing to chemoresistance and cancer stem cell populations. Targeting EMT in EOC thus offers an attractive therapeutic option.

Loading

Article metrics loading...

/content/journals/cdt/10.2174/138945012803530044
2012-12-01
2025-09-16
Loading full text...

Full text loading...

/content/journals/cdt/10.2174/138945012803530044
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test